IRCT20230724058907N1招募中3 期
Evaluation of nebulized heparin efficacy in pediatric patients with acute respiratory distress syndrome
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1 month 至 18 years（—）
- 性别
- All
入选标准
- •Children older than one month to 18 years old
- •The underlying disease of acute respiratory distress syndrome
- •Patients under mechanical ventilation for more than 48 hours with Pao2/Fio2<300
- •Patients who are expected to undergo invasive ventilation in the next 24 hours
- •In CXR, bilateral pulmonary infiltration can be seen (5cmH2O PEEP>)
排除标准
- •History of allergy to heparin
- •Bleeding history in the last 3 months
- •History of any bleeding and coagulation disorders
- •History of cerebral hemorrhage in the last year
- •Uncontrolled active bleeding
- •Simultaneous use of antiplatelet, anticoagulant and thrombolytic drugs
- •Unwillingness to participate in the study
研究者
相似试验
尚未招募
2 期
The Evaluation of effectiveness of heparin nebulizer in reduction of respiratory distress in patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210513051275N1Islamic Azad University60
已完成
3 期
Evaluation of the effect of nebulized heparin on days without ventilator in intensive care unit patientsAcute respiratory distress syndrom.Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vaporsJ68.3IRCT20211010052718N2Mazandaran University of Medical Sciences74
已完成
2 期
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart diseaseIRCT201202199080N1Hamadan university of medical sciences500
已完成
3 期
Investigation of the effect of inhaled heparin in the treatment of patients with adult respiratory distress syndrome hospitalized in the intensive care unitAcute respiratory distress syndrome.Acute respiratory distress syndromeIRCT20190506043492N4Ahvaz University of Medical Sciences60
招募中
3 期
Comparison of inhaled heparin/N-acetylcysteine, N-acetylcystein alone, and placepo for the treatment of COVID-19 patientsCOVID-19.Coronavirus infection, unspecifiedB34.2IRCT20201210049672N1Vice-Chancellery for Research Hormozgan University of Medical Sciences25